Drugs

Category / Pharmaceuticals & Biotech / Drugs

Soricimed Biopharma Inc. Announces U.S. Trial Site for Phase I Clinical Trial of New Cancer Drug, SOR-C13

Xylitol Canada Inc. Financial Results for Three Months Ended March 31, 2013

Biologix Hair Inc. Appoints Mark Maybank to its Board of Directors

SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market

SciClone Reports Anticipated Financial Results for the First Quarter 2013

Healthcare Corporation of America Revenue Increases 110% in the First Quarter of 2013 Year-Over-Year

Rapid Micro Biosystems Announces Hands-On Workshops at New European Headquarters in Munich, Germany

BEDFORD, MA and FREISING, GERMANY: Company Hosts Live Demonstrations of the Growth Direct(TM) System ...

Biologix Hair Inc. Appoints Dr. Michael Stocker Director and Chief Executive Officer; J. Gregory Wilson Appointed Chief Financial Officer

International Stem Cell Corporation to Present at Two Upcoming Investor Conferences

NuPathe Announces First Quarter 2013 Financial Results and Operational Highlights

Biologix Hair Inc. Appoints Ken Zadoorian to Board of Directors

Sirona Biochem to Present at 2nd Annual Marcum MicroCap Conference in New York

NuPathe Announces Allowance of Additional U.S. Patent Application for NP201

Xylitol Canada Inc. Announces Advance Notice By-Law

BREO(TM) ELLIPTA(TM) Gains US Approval for the Treatment of COPD

Biologix Hair Inc. Appoints Two-Component Mixing and Delivery Systems Expert Wilhelm A. Keller Director

Biologix Hair Inc. Strengthens Medical Advisory Board With Addition of Hair Transplant Surgeon Alan J. Bauman, MD

Sirona Biochem Corporation-CEO's Report on Progress, May 7, 2013

NuPathe to Host Conference Call to Discuss First Quarter 2013 Results on Tuesday, May 14, 2013

Biotie: Selincro Launched in the United Kingdom

Page 40 von 64: 1 « .. 39 40 41 42 43 44 45 46 47 48 .. » 64

Drugs

Category / Pharmaceuticals & Biotech / Drugs

Soricimed Biopharma Inc. Announces U.S. Trial Site for Phase I Clinical Trial of New Cancer Drug, SOR-C13

Xylitol Canada Inc. Financial Results for Three Months Ended March 31, 2013

Biologix Hair Inc. Appoints Mark Maybank to its Board of Directors

SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market

SciClone Reports Anticipated Financial Results for the First Quarter 2013

Healthcare Corporation of America Revenue Increases 110% in the First Quarter of 2013 Year-Over-Year

Rapid Micro Biosystems Announces Hands-On Workshops at New European Headquarters in Munich, Germany

Biologix Hair Inc. Appoints Dr. Michael Stocker Director and Chief Executive Officer; J. Gregory Wilson Appointed Chief Financial Officer

International Stem Cell Corporation to Present at Two Upcoming Investor Conferences

NuPathe Announces First Quarter 2013 Financial Results and Operational Highlights

Biologix Hair Inc. Appoints Ken Zadoorian to Board of Directors

Sirona Biochem to Present at 2nd Annual Marcum MicroCap Conference in New York

NuPathe Announces Allowance of Additional U.S. Patent Application for NP201

Xylitol Canada Inc. Announces Advance Notice By-Law

BREO(TM) ELLIPTA(TM) Gains US Approval for the Treatment of COPD

Biologix Hair Inc. Appoints Two-Component Mixing and Delivery Systems Expert Wilhelm A. Keller Director

Biologix Hair Inc. Strengthens Medical Advisory Board With Addition of Hair Transplant Surgeon Alan J. Bauman, MD

Sirona Biochem Corporation-CEO's Report on Progress, May 7, 2013

NuPathe to Host Conference Call to Discuss First Quarter 2013 Results on Tuesday, May 14, 2013

Biotie: Selincro Launched in the United Kingdom